Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
A. Nascimento
Observed name:
A. M. Nascimento
Institutions:
Hospital Sant Joan de Déu Barcelona,
Centre for Biomedical Network Research on Rare Diseases,
Institut de Recerca Sant Joan de Déu
Observed institutions:
Hospital Sant Joan de Déu Barcelona,
Instituto de Salud Carlos III,
Centre for Biomedical Network Research on Rare Diseases,
Hospital Universitario de Fuenlabrada,
Institut de Recerca Sant Joan de Déu
ORCID:
0000-0002-7553-8337
Observed ORCID:
0000-0002-7553-8337
OpenAlex ID:
A5103153341
Digital PCR quantification of miR-30c and miR-181a as serum biomarkers in Duchenne muscular dystrophy
2016
·
M. Llano-Diez
, C. Ortez
, et al.
·
Neuromuscular Disorders
·
4
Dmd Clinical Therapies I
2018
·
C. Ortez
, J. Medina
, et al.
·
Neuromuscular Disorders
·
2
166PEarly functional trajectories in young boys with Duchenne muscular dystrophy: a 24-month international study using the NSAA
2025
·
G. Coratti
, S. Paolucci
, et al.
·
Neuromuscular Disorders
·
1
423P Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne muscular dystrophy: phase 3 EMBARK primary results
2024
·
J. Mendell
, F. Muntoni
, et al.
·
Neuromuscular Disorders
·
1
Corticosteroid treatment in early-onset lamin A/C related muscular dystrophies
2017
·
I. Dabaj
, R. Ben Yaou
, et al.
·
Neuromuscular Disorders
·
1
First results from the international LMNA-related congenital and childhood onset muscular dystrophy retrospective natural history study
2017
·
R. Ben Yaou
, I. Dabaj
, et al.
·
Neuromuscular Disorders
·
1
P37 A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome
2012
·
A. Chaouch
, J.S. Müller
, et al.
·
Neuromuscular Disorders
·
1
Long-Term Functional Outcomes, Safety, and Micro-Dystrophin Expression Following Delandistrogene Moxeparvovec Treatment in DMD: EMBARK 2-Year Results
2025
·
I. Seelmann
, J. R. Mendell
, et al.
·
Neuropediatrics
142PPhenotypical and genotypical characterization of a cohort of 196 COL6-RD patients in Europe and Chile
2025
·
M. Bisciglia
, T. Stojkovic
, et al.
·
Neuromuscular Disorders
05ORedefining triple a syndrome: a multinational study of the neuromuscular phenotype in the largest genetically confirmed cohort to date
2025
·
M. Oeztuerk
, S. Leonard-Louis
, et al.
·
Neuromuscular Disorders
PCR257 Real-World Impact of X-Linked Myotubular Myopathy (XLMTM) on Caregivers in the United Kingdom (UK), Germany, and Spain
2024
·
T. Haselkorn
, W. Hughes
, et al.
·
Value in Health
237P Advancing the understanding of VAMP1-related congenital myasthenic syndrome: phenotypic insights, favorable response to 3,4-diaminopyridine, and clinical characterization of five new cases
2024
·
D. Natera De Benito
, A. Pugliese
, et al.
·
Neuromuscular Disorders
511P Blood biomarkers in a cohort of patients with CHRNE-associated congenital myasthenic syndrome
2024
·
A. Della Marina
, A. Koutsoulidou
, et al.
·
Neuromuscular Disorders
Safety and Efficacy of Delandistrogene Moxeparvovec versus Placebo in Duchenne Muscular Dystrophy (EMBARK): Pivotal Phase 3 Primary Results
2024
·
I. Seelmann
, J. R. Mendell
, et al.
·
Neuropediatrics
OTHER NMDs
2021
·
M. Keogh
, A. Topf
, et al.
·
Neuromuscular Disorders
PDF
Congenital Muscular Dystrophies
2020
·
D. Natera-de Benito
, A. Reghan-Foley
, et al.
·
Neuromuscular Disorders
Hereditary Neuropathies & Als
2020
·
E. Bobadilla-Quesada
, G. Nolasco
, et al.
·
Neuromuscular Disorders
X-Linked myotubular myopathy (XLMTM): phenotypic variability
2017
·
C. Ortez
, D. Natera
, et al.
·
Neuromuscular Disorders
PP09.7 – 2375: Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE1267delG mutation. A long-term follow-up
2015
·
D. Natera-de Benito
, J. Domínguez-Carral
, et al.
·
European Journal of Paediatric Neurology
P2.42 Cys150Arg FHL1 mutation in two brothers affected by the Emery-Dreifuss muscular dystrophy phenotype
2011
·
C. Ortez
, A. Nascimento
, et al.
·
Neuromuscular Disorders
M.P.1.05 Successful long-term acethylcholinesterase inhibitor therapy in patients affected by Rapsyn (RAPSN) mutation early onset phenotype
2008
·
A. Nascimento
, J. Colomer
, et al.
·
Neuromuscular Disorders
G.P.10.04 Long term positive response to cholinesterase inhibitors in a patient with DOK7 mutation
2007
·
J. Colomer
, A. Nascimento
, et al.
·
Neuromuscular Disorders
Reaction of Primary Amines with 1-Pyrazole-1-carboximidamides
2005
·
R. G. S. Berlinck
, M. H. Kossuga
, et al.
·
Four Carbon-Heteroatom Bonds
Solid-Phase Synthesis of Amines with Methylisothioureas
2005
·
R. G. S. Berlinck
, M. H. Kossuga
, et al.
·
Four Carbon-Heteroatom Bonds
Reaction of Primary Amines with -Methylisoureas
2005
·
R. G. S. Berlinck
, M. H. Kossuga
, et al.
·
Four Carbon-Heteroatom Bonds
Show more works
View as search
Works count:
29
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type